戊戌数据药品标准数据库提供了Sodium Chloride Ophthalmic Solution美国药典标准的查询检索,包括Sodium Chloride Ophthalmic Solution美国药典的版本USP35-NF30页码,以及药典的查询与下载.
cromolyn sodium ophthalmic solutionusp 色甘酸钠滴眼液 1) 适应症 色甘酸钠滴眼液，用于预防春季过敏性结膜炎。2) 用法用量 外用滴眼。一次1-2滴，一日4次；重症者可增加至一日6次。在好发季节提前2-3周使用。3) 注意事项 1.使用后应将药瓶盖拧紧，以免瓶口污染。2.用前应洗净双手。3.对本品...
SULFACETAMIDE SODIUM OPHTHALMIC OINTMENT, USP (SUPERSEDING MIL-S-37404) (NO S/S DOCUMENT)doi:CID A-A-54531
戊戌数据药品标准数据库提供了Sulfacetamide sodium ophthalmic Ointment美国药典标准的查询检索,包括Sulfacetamide sodium ophthalmic Ointment美国药典的版本USP43-NF38页码,以及药典的查询与下载.
Ophthalmic: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections. Other: Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, injection sit...
dihydrogenphosphatedihydrate; MonosodiumPhosphateFoodGradeHydrous; Phosphoricacid,monosodiumsalt,dihydrate; Phosphoricacidmonosodiumsalt,dihydrate; Sodium phosphate,monobasic dihydrate; Sodiumdihydrogenphosphate,di; SodiumDihydrogenPhosphateDihydrateBp; SodiumDihydrogenPhosphateDihydrateIp; SodiumDihydrogenPhosphateDihydrateUsp;...
Sodium acetate is used as part of a buffer system when combined with acetic acid in various intramuscular, intravenous, topical, ophthalmic, nasal, oral, otic, and subcutaneous formulations. It may be used to reduce the bitterness of oral pharmaceuticals. It can be used to enhance the antimicrob...
Miconazole and Hydrocortisone Ointment; USP 31: Chloramphenicol and Hydrocortisone Acetate for Ophthalmic Suspension; Chloramphenicol, Polymyxin B Sulfate, and Hydrocortisone Acetate Ophthalmic Ointment; Clioquinol and Hydrocortisone Cream; Clioquinol and Hydrocortisone Ointment; Colistin and Neomycin Sulfates and ...
2846Dexamethasone/OfficialMonographsUSP35 rateofabout1.6mLperminute,givesaretentiontimeofquantity,inmg,ofCHFOPintheportionofOphthalmic 22308 about5minutesfordexamethasonephosphate.Ointmenttakenbytheformula: Standardpreparation—[NOTE—Preparethissolutionatthe 0.1C(r/r). timeofuse.]Dissolveanaccuratelyweighedquanti...
27. The pharmaceutical composition of claim 25, wherein the composition is formulated for oral, parenteral, inhalation, nasal, intravesical, vaginal, rectal, sublingual, ophthalmic, or topical administration. 28. The pharmaceutical composition of claim 27, wherein the composition is formulated for pare...